1. Neurophysiology and neurochemistry of corticobasal syndrome

   • Aditya A. Murgai
   • Mandar S. Jog

   Review 06 January 2018 Pages: 991 - 998

2. Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis

   • X. Armoiry
   • A. Kan
   • A. Clarke

   Review Open access 22 January 2018 Pages: 999 - 1009

   

3. Smoking at time of CIS increases the risk of clinically definite multiple sclerosis

   • Roos M. van der Vuurst de Vries
   • Julia Y. Mescheriakova
   • Rogier Q. Hintzen

   Original Communication Open access 20 February 2018 Pages: 1010 - 1015

   

4. Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years

   • Sarah D. Broicher
   • Linard Filli
   • M. Linnebank

   Original Communication 20 February 2018 Pages: 1016 - 1025

   

5. The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy

   • Angela Rosenbohm
   • Susanne Hirsch
   • Albert C. Ludolph

   Original Communication 20 February 2018 Pages: 1026 - 1036

   

6. Increased platelet count and reticulated platelets in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic signal-negative patient subgroups: results from the HaEmostasis In carotid STenosis (HEIST) study

   • S. J. X. Murphy
   • S. T. Lim
   • For the HEIST study group

   Original Communication 23 February 2018 Pages: 1037 - 1049

   

7. Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)

   • Roberto Monastero
   • Calogero Edoardo Cicero
   • Alessandra Nicoletti

   Original Communication 24 February 2018 Pages: 1050 - 1058

8. Growing older with drug-resistant epilepsy: cognitive and psychosocial outcomes

   • Rani A. Sarkis
   • Scott McGinnis
   • Kim C. Willment

   Original Communication 24 February 2018 Pages: 1059 - 1064

   

9. University education and cervical artery dissection

   • Lars Kellert
   • Armin Grau
   • for the Cervical Artery Dissection and Ischemic Stroke Patients (CADISP)-Study Group

   Original Communication 24 February 2018 Pages: 1065 - 1070

10. Cortico-spinal excitability and hand motor recovery in stroke: a longitudinal study

    • Jitka Veldema
    • Kathrin Bösl
    • Dennis Alexander Nowak

    Original Communication 28 February 2018 Pages: 1071 - 1078

    

11. [¹⁸F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation

    • F. Ali
    • J. L. Whitwell
    • K. A. Josephs

    Original Communication 01 March 2018 Pages: 1079 - 1088

    

12. No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation

    • Stephen Keddie
    • Ashok Adams
    • Alastair J. Noyce

    Original Communication Open access 03 March 2018 Pages: 1089 - 1095

    

13. Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case–control MRI study

    • Lorena Lorefice
    • Giuseppe Fenu
    • Eleonora Cocco

    Original Communication 05 March 2018 Pages: 1096 - 1101

14. Adult normative values for the PATA Rate Test

    • Chiara Pane
    • Teresa Costabile
    • Francesco Saccà

    Original Communication 06 March 2018 Pages: 1102 - 1105

    

15. The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis

    • Tilman Hottenrott
    • Elisabeth Schorb
    • Oliver Stich

    Original Communication 06 March 2018 Pages: 1106 - 1114

    

16. Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation

    • E. C. Tallantyre
    • D. H. Whittam
    • A. Jacob

    Original Communication Open access 06 March 2018 Pages: 1115 - 1122

    

17. Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation

    • E. C. Tallantyre
    • D. H. Whittam
    • A. Jacob

    Correction Open access 07 April 2018 Pages: 1123 - 1123

18. Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study

    • Alessandro Tessitore
    • Pietro Marano
    • Angelo Antonini

    Original Communication Open access 07 March 2018 Pages: 1124 - 1137

    

19. First-trial protective step performance before and after short-term perturbation practice in people with Parkinson’s disease

    • J. S. Barajas
    • D. S. Peterson

    Original Communication 08 March 2018 Pages: 1138 - 1144

    

20. Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration

    • Shinji Aoyama
    • Masahiro Mori
    • Satoshi Kuwabara

    Original Communication 12 March 2018 Pages: 1145 - 1150

    

21. Patient experiences of receiving a diagnosis of Parkinson’s disease

    • A. Schrag
    • S. Modi
    • A on behalf of the European Parkinson’s Disease Association

    Original Communication Open access 15 March 2018 Pages: 1151 - 1157

    

22. Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL

    • Roland Opfer
    • Ann-Christin Ostwaldt
    • Sven Schippling

    Original Communication 16 March 2018 Pages: 1158 - 1165

    

23. Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke

    • Sixtine Gilliot
    • Igor Sibon
    • The OPHELIE Investigators

    Original Communication 16 March 2018 Pages: 1166 - 1173

24. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study

    • Roberta Lanzillo
    • Luca Prosperini
    • R.I.Re.MS study group

    Original Communication 16 March 2018 Pages: 1174 - 1183

    

25. Why acute unilateral vestibular midbrain lesions rarely manifest with rotational vertigo: a clinical and modelling approach to head direction cell function

    • Marianne Dieterich
    • Stefan Glasauer
    • Thomas Brandt

    Original Communication Open access 16 March 2018 Pages: 1184 - 1198

    

26. Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

    • Bryan Ceronie
    • Benjamin M. Jacobs
    • Klaus Schmierer

    Original Communication Open access 17 March 2018 Pages: 1199 - 1209

    

27. The Dizziness Handicap Inventory does not correlate with vestibular function tests: a prospective study

    • Chun Wai Yip
    • Michael Strupp

    Original Communication 20 March 2018 Pages: 1210 - 1218

    

28. Hemi-seesaw nystagmus in a patient with acute infarction in the superior cerebellar artery territory

    • Hyung Lee
    • Hyun Ah Kim

    Letter to the Editors 23 March 2018 Pages: 1219 - 1221

    

29. Lower brainstem melanocytoma masquerading as vestibular paroxysmia

    • Sun-Uk Lee
    • Hyo-Jung Kim
    • Ji-Soo Kim

    Letter to the Editors 17 April 2018 Pages: 1222 - 1225

    

30. Induction of disease remission with one cycle of alemtuzumab in relapsing–remitting MS

    • Alexandra S. Kocsik
    • David E. Klein
    • Jai S. Perumal

    Short Commentary 17 April 2018 Pages: 1226 - 1229

    

31. Movement disorders in mitochondrial disease

    • Roula Ghaoui
    • Carolyn M. Sue

    Neurological Update 06 January 2018 Pages: 1230 - 1240

    

32. Biomarkers for traumatic brain injury

    • Ronak Ved
    • Malik Zaben

    Journal club Open access 10 April 2018 Pages: 1241 - 1243

33. Macdonald Critchley (1900–1997)

    • Stefano Sandrone
    • Jan van Gijn

    Pioneers in Neurology 21 November 2017 Pages: 1244 - 1245

34. Acknowledgement to Reviewers 2017

    Acknowledgement 19 April 2018 Pages: 1246 - 1250